Interpatient variability in bioavailability is related to the extent of absorption: Implications for bioavailability and bioequivalence studies
- 23 December 1996
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 60 (6) , 601-607
- https://doi.org/10.1016/s0009-9236(96)90208-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Women in Bioavailability/Bioequivalence Trials — A Regulatory PerspectiveDrug Information Journal, 1995
- Current Scientific Issues regarding Bioavailability/Bioequivalence Studies: An Academic ViewDrug Information Journal, 1995
- Current Issues in Bioequivalence TrialsDrug Information Journal, 1995
- On the assessment of variability in bioavailability/bioequivalence studiesCommunications in Statistics - Theory and Methods, 1992
- Bioequivalence and intrasubject variabilityJournal of Biopharmaceutical Statistics, 1991
- Consideration of individual bioequivalenceJournal of Pharmacokinetics and Biopharmaceutics, 1990
- Statistical Simulation Study of New Proposed Uniformity Requirement for Bioequivalency StudiesJournal of Pharmaceutical Sciences, 1981